The International Journal of Clinical Medical Research is committed to upholding the highest standards of scientific integrity and ethical compliance in clinical research. To ensure transparency, reproducibility, and protection of patient rights, authors submitting clinical studies to our journals must adhere to the following policies regarding clinical data:

1. Ethical Approval and Informed Consent
   All clinical research involving human participants must have obtained prior approval from a recognized Institutional Review Board (IRB) or Ethics Committee. The manuscript must include the name of the approving body and the ethical approval reference number. Authors must also confirm that informed consent was obtained from all participants, with documentation available upon request.

2. Clinical Trial Registration
   Clinical trials must be registered prospectively in a publicly accessible and recognized clinical trial registry, such as ClinicalTrials.gov or the Chinese Clinical Trial Registry. The registration number should be clearly stated in the manuscript’s abstract and/or methods section.

3. Data Transparency and Completeness
   Authors are required to provide comprehensive and detailed descriptions of clinical data, including patient inclusion and exclusion criteria, study design, interventions, primary and secondary outcome measures, and statistical analysis methods. Wherever possible, authors are encouraged to submit raw or supplementary data to support their findings and facilitate peer review.

4. Patient Privacy and Data Protection
   Authors must ensure that all patient information is anonymized and that no personally identifiable information is disclosed. All clinical data handling must comply with relevant data protection regulations such as GDPR or HIPAA, as applicable.

5. Reporting of Adverse Events
   Any adverse events or complications encountered during the study must be fully documented and discussed in the manuscript, including their management and outcomes.